Armata Pharmaceuticals
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5005 Mcconnell Ave, Los Angeles, Califor...Phone Number
(858) 829-0829Website
www.armatapharma.comRevenue
$5.2 MillionStock Symbol
ARMPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Armata Pharmaceuticals
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. Armata Pharmaceuticals was founded in 2005 and based in Marina del Rey, California.Explore more
Armata Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Armata Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Armata Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Armata Pharmaceuticals launches new products
Armata Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Armata Pharmaceuticals has new funding data
Earning: See what the market has to say on Armata Pharmaceuticals recently announced quarterly report
Check if Armata Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Armata Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Armata Pharmaceuticals
Recommended Actions
Reach out to Masked Content who joined Armata Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Armata Pharmaceuticals
Compare insights from companies similar to Armata Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Armata Pharmaceuticals
$5.2M
51-200
Public
$143.8M
1989
JS
Jennifer SmithLead, Clinical Operations Chief of Staff
Company Profile Activity
Activity Insights
Armata Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Armata Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Armata Pharmaceuticals.
Armata Pharmaceuticals financials insights
Gather financial insights about Armata Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$13.3M
2014
Series D
$60.5M
Unspecified
$5M
2021
Share Placement
$20M
2022
Share Placement
$45M
Armata Pharmaceuticals Tech Stack
A closer look at the technologies used by Armata Pharmaceuticals
Most Recent Scoops
Earnings
Earnings, Finance
Person-Based
Stake & Stock Ownership, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings
Armata Pharmaceuticals News & Media
Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
Fulfills important regulatory milestone for AP-SA02 on the path toward a future BLA and supports expansion into pediatric patients LOS ANGELES, July 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology...Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
Supports Phase 3 readiness of AP-SA02 Non-dilutive DoD funding totals $28.7M to date LOS ANGELES, June 23, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of...Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy?
Armata Pharmaceuticals Inc. (NYSE:ARMP) is one of the high-growth micro-cap stocks to buy now. On May 7, Armata Pharmaceuticals Inc. (NYSE:ARMP) achieved a significant milestone when the U.S Food and Drug Administration granted Fast Track Designation to AP-SA02. AP-SA02 is the company’s intravenously administered multi-phage product for the treatment of complicated bacteremia caused by Staphylococcus […]Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update
Entered into secured credit agreement with Innoviva for $25 million maturing in 2029 LOS ANGELES, May 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Armata Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. Armata Pharmaceuticals was founded in 2005 and based in Marina del Rey, California.... Read More
